日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shear-Sensing by C-Reactive Protein: Linking Aortic Stenosis and Inflammation

C反应蛋白介导的剪切力感知:连接主动脉瓣狭窄和炎症

Zeller, Johannes; Loseff-Silver, Julia; Khoshmanesh, Khashayar; Baratchi, Sara; Lai, Austin; Nero, Tracy L; Roy, Abhishek; Watson, Anna; Dayawansa, Nalin; Sharma, Prerna; Barbaro-Wahl, Anastasia; Chen, Yung Chih; Moon, Mitchell; Vidallon, Mark Louis P; Huang, Angela; Thome, Julia; Cheung Tung Shing, Karen S; Harvie, Dalton; Bongiovanni, Marie N; Braig, David; Morton, Craig J; Htun, Nay M; Stub, Dion; Walton, Anthony; Horowitz, John; Wang, Xiaowei; Pietersz, Geoffrey; Parker, Michael W; Eisenhardt, Steffen U; McFadyen, James D; Peter, Karlheinz

Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications

利用人血清白蛋白融合药物进行血小板靶向血栓预防:预防血栓形成并减少心肌缺血/再灌注损伤,且无出血并发症

Song, Yuyang; Bienvenu, Laura A; Bongcaron, Viktoria; Prijaya, Shania A; Maluenda, Ana C; Walsh, Aidan P G; McFayden, James D; Pietersz, Geoffrey A; Peter, Karlheinz; Wang, Xiaowei

In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications

体内荧光成像:临床前成像的成功为临床应用铺平了道路

Refaat, Ahmed; Yap, May Lin; Pietersz, Geoffrey; Walsh, Aidan Patrick Garing; Zeller, Johannes; Del Rosal, Blanca; Wang, Xiaowei; Peter, Karlheinz

Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

纳米生物技术在心血管疾病治疗中的应用:药物和纳米颗粒的靶向治疗动脉粥样硬化血栓形成

Liu, Haikun; Pietersz, Geoffrey; Peter, Karlheinz; Wang, Xiaowei

Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2

FcγRIIa 与 Fc 的结合对于抗 FcγRIIa 单克隆抗体 8.26 和 8.2 激活细胞至关重要。

Wines, Bruce D; Trist, Halina M; Esparon, Sandra; Impey, Rachael E; Mackay, Graham A; Andrews, Robert K; Soares da Costa, Tatiana P; Pietersz, Geoffrey A; Baker, Ross I; Hogarth, P Mark

CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma

CD83是霍奇金淋巴瘤的一种新的潜在生物标志物和治疗靶点。

Li, Ziduo; Ju, Xinsheng; Lee, Kenneth; Clarke, Candice; Hsu, Jennifer L; Abadir, Edward; Bryant, Christian E; Pears, Suzanne; Sunderland, Neroli; Heffernan, Scott; Hennessy, Annemarie; Lo, Tsun-Ho; Pietersz, Geoffrey A; Kupresanin, Fiona; Fromm, Phillip D; Silveira, Pablo A; Tsonis, Con; Cooper, Wendy A; Cunningham, Ilona; Brown, Christina; Clark, Georgina J; Hart, Derek N J

Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides

穿透肽和TAT细胞穿透肽递送的细胞毒性T细胞表位的比较免疫原性

Brooks, Nicole; Esparon, Sandra; Pouniotis, Dodie; Pietersz, Geoffrey A

Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.

向小鼠鼻内注射甘露聚糖佐剂灭活流感病毒,低剂量即可诱导肺部产生强烈的血清 IgG 和 IgA

Proudfoot Owen, Esparon Sandra, Tang Choon-Kit, Laurie Karen, Barr Ian, Pietersz Geoffrey

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

一项针对晚期上皮性卵巢癌患者的自体树突状细胞治疗(针对黏蛋白1)的II期单臂研究

Mitchell, Paul Lr; Quinn, Michael A; Grant, Peter T; Allen, David G; Jobling, Thomas W; White, Shane C; Zhao, Anne; Karanikas, Vaios; Vaughan, Hilary; Pietersz, Geoffrey; McKenzie, Ian Fc; Gargosky, Sharron E; Loveland, Bruce E

Dendritic cell immunotherapy: clinical outcomes

树突状细胞免疫疗法:临床结果

Apostolopoulos, Vasso; Pietersz, Geoffrey A; Tsibanis, Anastasios; Tsikkinis, Annivas; Stojanovska, Lily; McKenzie, Ian Fc; Vassilaros, Stamatis